Changchun BCHT Biotechnology Co. (688276.SS)
CNY 26.21
(-0.53%)
CNY 26.21
(-0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 192.59 Million | 39.81 Million | 140.3 Million | 209.16 Million | 232.79 Million | 269.79 Million |
| Net Income | 501 Million | 181.53 Million | 243.55 Million | 418.23 Million | 221.02 Million | 128.05 Million |
| Depreciation & Amortization | 98.99 Million | 70.94 Million | 68.33 Million | 58.85 Million | 42.76 Million | 31.79 Million |
| Deferred income taxes | -35.4 Million | -21.15 Million | -10.96 Million | -11.91 Million | 1.15 Million | -510.8 Thousand |
| Stock-based compensation | 32.24 Million | 5.32 Million | - | - | - | 70.98 Million |
| Change in working capital | -397.24 Million | -293.72 Million | -269.14 Million | -265.64 Million | -44.51 Million | 93.41 Million |
| Other non-cash items | 620.48 Million | 96.9 Million | 97.55 Million | -2.28 Million | 13.52 Million | 16.52 Million |
| Investing Cash Flow | -638.62 Million | -288.71 Million | -695.5 Million | -333.59 Million | -128.39 Million | -154.76 Million |
| Investments in PPE | -470.66 Million | -290.73 Million | -632.87 Million | -335.74 Million | -128.39 Million | -181.15 Million |
| Acquisitions | 36 Thousand | - | 632.89 Million | 335.74 Million | - | 26.38 Million |
| Investment purchases | -168 Million | - | -66 Million | -320 Million | - | - |
| Sales/Maturities of investments | 167.96 Million | 2.01 Million | 3.35 Million | 322.15 Million | - | - |
| Other Investing Activities | -167.96 Million | 0.41 | -632.87 Million | -335.74 Million | -128.39 Million | 26.38 Million |
| Financing Cash Flow | 20.47 Million | -41.28 Million | 1.4 Billion | 174.39 Million | -56.69 Million | -38.46 Million |
| Debt repayment | -20.47 Million | - | -67.5 Million | -234.89 Million | -148.19 Million | -522.5 Million |
| Dividends payments | -62.61 Million | -41.28 Million | -328.77 Thousand | -4.04 Million | -8.29 Million | -18.46 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -10.07 Million | - | - | - |
| Other Financing Activities | 103.55 Million | - | 1.4 Billion | 413.33 Million | 99.8 Million | 502.5 Million |
| Accounts receivables | -691.36 Million | -171.35 Million | -40.03 Million | -418.57 Million | -48.14 Million | -39 Million |
| Accounts payables | 327.64 Million | -109.09 Million | -51.66 Million | 224.56 Million | -7.59 Million | 112.88 Million |
| Inventory | -33.53 Million | 7.88 Million | -166.47 Million | -59.72 Million | 10.06 Million | 20.04 Million |
| Other working capital | 292.24 Million | -21.15 Million | -10.96 Million | -11.91 Million | 1.15 Million | 73.36 Million |
| Cash at beginning of period | 866.54 Million | 1.15 Billion | 303.06 Million | 253.2 Million | 205.39 Million | 128.87 Million |
| Cash at end of period | 442.17 Million | 861.6 Million | 1.15 Billion | 303.06 Million | 253.2 Million | 205.39 Million |
| Capital Expenditure | -470.66 Million | -290.73 Million | -632.87 Million | -335.74 Million | -128.39 Million | -181.15 Million |
| Effect of forex changes on cash | 503.13 Thousand | 1.66 Million | -97.35 Thousand | -100.4 Thousand | 97.95 Thousand | -42.35 Thousand |
| Net cash flow / Change in cash | -424.36 Million | -288.51 Million | 847.05 Million | 49.86 Million | 47.8 Million | 76.51 Million |
| Free Cash Flow | -278.06 Million | -250.91 Million | -492.57 Million | -126.58 Million | 104.4 Million | 88.64 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 77.03 Million | 60.56 Million | 501 Million | 169.91 Million | 219.7 Million |
| Depreciation & Amortization | - | 35.94 Million | 35.94 Million | 98.99 Million | 23.74 Million | -47.09 Million |
| Deferred income taxes | - | - | - | -35.4 Million | 692.64 Million | -86.38 Million |
| Stock-based compensation | - | 9.46 Million | - | 32.24 Million | 32.24 Million | -15.91 Million |
| Change in working capital | - | -79.12 Million | - | -397.24 Million | -724.89 Million | 149.39 Million |
| Other non-cash items | - | 52.28 Million | -68.49 Million | 620.48 Million | 571.81 Million | -174.41 Million |
| Investing Cash Flow | -179.26 Million | -126.99 Million | -86.29 Million | -638.62 Million | -147.68 Million | -105.61 Million |
| Investments in PPE | -179.26 Million | -126.99 Million | -86.29 Million | -470.66 Million | -147.71 Million | -99.61 Million |
| Acquisitions | - | - | - | 36 Thousand | 36 Thousand | - |
| Investment purchases | - | - | - | -168 Million | - | -6 Million |
| Sales/Maturities of investments | - | - | - | 167.96 Million | - | - |
| Other Investing Activities | - | 941.29 Thousand | - | -167.96 Million | 36 Thousand | -6 Million |
| Financing Cash Flow | -44.21 Million | -2.46 Million | 44.41 Million | 20.47 Million | 57.23 Million | -52.61 Million |
| Debt repayment | -43.86 Million | -41.04 Million | -44.93 Million | -20.47 Million | -20.47 Million | -78.71 Million |
| Dividends payments | -346.83 Thousand | -62.51 Million | -516.11 Thousand | -62.61 Million | -25.85 Million | -336.24 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -43.51 Million | -516.11 Thousand | 103.55 Million | 103.55 Million | 26.44 Million |
| Accounts receivables | - | 7.08 Million | - | -691.36 Million | -691.36 Million | 100.25 Million |
| Accounts payables | - | - | - | 327.64 Million | - | - |
| Inventory | - | -86.2 Million | - | -33.53 Million | -33.53 Million | 49.14 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 351.23 Million | 392.47 Million | 442.17 Million | 866.54 Million | 459.4 Million | 567.53 Million |
| Cash at end of period | 272.25 Million | 356.86 Million | 392.47 Million | 442.17 Million | 442.17 Million | 454.46 Million |
| Capital Expenditure | -179.26 Million | -126.99 Million | -86.29 Million | -470.66 Million | -147.71 Million | -99.61 Million |
| Effect of forex changes on cash | -98.1 Thousand | 473.23 Thousand | 108.58 Thousand | 503.13 Thousand | -298.95 Thousand | -138.98 Thousand |
| Net cash flow / Change in cash | -78.97 Million | -35.61 Million | -49.7 Million | -424.36 Million | -17.22 Million | -113.06 Million |
| Free Cash Flow | -179.26 Million | -33.61 Million | -94.22 Million | -278.06 Million | -74.88 Million | -54.31 Million |
KIERF
005930
KRRO
300331
TRST
ATRO